BDO Wealth Advisors, LLC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 35 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BDO Wealth Advisors, LLC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$893
-44.1%
4,7000.0%0.00%
Q1 2023$1,598
+5.1%
4,7000.0%0.00%
Q4 2022$1,520
-24.0%
4,7000.0%0.00%
Q3 2022$2,0000.0%4,7000.0%0.00%
Q2 2022$2,000
-71.4%
4,7000.0%0.00%
-100.0%
Q2 2021$7,000
-58.8%
4,7000.0%0.00%
-66.7%
Q2 2020$17,000
+54.5%
4,7000.0%0.00%
+50.0%
Q1 2020$11,0004,7000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q1 2023
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders